Captor Therapeutics
CTX.WA
#9394
Rank
โ‚น12.17 B
Marketcap
โ‚น1,923
Share price
0.00%
Change (1 day)
96.92%
Change (1 year)

Revenue for Captor Therapeutics (CTX.WA)

Revenue in 2026 (TTM): โ‚น57.25 Million

According to Captor Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น63.65 Million. In 2025 the company made a revenue of โ‚น0.11 Billion a decrease over the revenue in the year 2024 that were of โ‚น0.34 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Captor Therapeutics from 2021 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น57.25 M-48.77%
2025 โ‚น0.11 B-67.21%
2024 โ‚น0.34 B26.62%
2023 โ‚น0.26 B56.97%
2022 โ‚น0.17 B128.55%
2021 โ‚น75.02 M